Bolocon, Ferlyn C.
HRN: 23-62-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/26/2024
CEFUROXIME 500MG (TAB)
02/26/2024
03/04/2024
PO
500mg
BID X 7 Days
S/P NSVD With RMLE And Repair; PROM X 16hrs
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes